Abstract: The present invention is intended to provide a gasket which is able to be mounted on a plunger with a loosening preventing mechanism and, more specifically, a gasket including loosening preventing means provided for the plunger having a mechanism configured to prevent a joint portion between the plunger and the gasket from loosening, and a prefilled syringe preparation utilizing this gasket. The gasket is mountable on the plunger having a projecting portion in a groove of a screw portion for screwing the gasket thereon including a depressed portion with which the projecting portion is engageable when being screwed on the plunger provided on an inner periphery of the gasket.
Type:
Application
Filed:
October 15, 2008
Publication date:
February 3, 2011
Applicant:
Taiyo Pharmaceutical Industry Co., Ltd.
Abstract: The invention provides an indene compound represented by the following general formula (I): ##STR1## wherein R.sub.1 means a lower alkyl group, R.sub.2 and R.sub.3 denote a lower alkyl group individually or an alkylenedioxy group in combination, and R.sub.4 and R.sub.5 mean individually a substituted or unsubstituted lower alkyl or aryl group or in combination a substituted or unsubstituted piperidino, piperazinyl or homopiperazinyl group together with the adjacent nitrogen atom, with a proviso that not both R.sub.4 and R.sub.5 are a methyl group at the same time.
Abstract: An indene compound of the general formula (I): ##STR1## in which R.sub.1 represents a lower alkyl group, R.sub.2 represents a hydrogen atom, an aryl group or lower alkyl group, R.sub.3 represents an alkyl group, and n indicates an integer of 2 or 3; or a salt thereof. The compound has very strong ameliorating or improving effects on cerebral circulation and metabolism, and thus is very useful for ameliorating, or suppressing the progress of, disturbances of brain tissues and functions.
Abstract: The invention provides an indene compound represented by the following general formula (I): ##STR1## wherein R.sub.1 means a lower alkyl group, R.sub.2 and R.sub.3 denote a lower alkyl group individually or an alkylenedioxy group in combination, and R.sub.4 and R.sub.5 mean individually a substituted or unsubstituted lower alkyl or aryl group or in combination a substituted or unsubstituted piperidino, piperazinyl or homopiperazinyl group together with the adjacent nitrogen atom, with a proviso that not both R.sub.4 and R.sub.5 are a methyl group at the same time.
Abstract: Disclosed herein is an oral mobenzoxamine preparation which comprises a clathrate compound of mobenzoxamine or a salt thereof and cyclodextrin. Since the clathrate compound remains extremely stable even when stored for a long period of time and its absorption through the digestive tract is good upon its oral administration, the clathrate compound can be used advantageously as an orally-dosable preparation.